AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Merck's Vioxx woes weigh on stocks.

The America's Intelligence Wire

| September 30, 2004 | COPYRIGHT 2003 Financial Times Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

(From AP Worldstream)

Byline: MICHAEL J. MARTINEZ

Wall Street closed out a dismal third quarter with a mixed performance Thursday after Merck & Co. said it would be forced to remove its best-selling Vioxx arthritis drug from the market. Merck's unexpected bad news left blue chips with a loss for the day, while high-tech stocks got a lift from bargain hunters.

Merck's troubles _ Vioxx was found to carry an increased risk of heart attack and stroke _ were magnified because the company is part of the Dow Jones industrials. Analysts said the Dow likely would have been flat to slightly higher without Merck's announcement.

Bad economic news also weighed on stocks as the Labor Department reported the highest increase in weekly first-time…

Related articles from newspapers, magazines, journals, and more
Merck Announces Tender Offer for Remaining Banyu Shares.
Press release article from: Business Wire September 11, 2003 700+ words
...currently owned by Merck or its affiliates equals 4.8 percent of total outstanding...The offer reflects Merck's intention, as...completed in March 2003, Merck increased its ownership...from approximately 51 percent to 95.2 percent...
Merck & Co., Inc. Plans to Establish Merck-Medco as a Separate, Publicly Traded...
Press release article from: Business Wire January 29, 2002 700+ words
...of the New Company Expected by Mid-2002 Merck & Co., Inc. today announced plans to establish Merck-Medco, its pharmacy benefits management...as a separate, publicly traded company. Merck plans an initial public offering of a portion...
Merck Announces Prescription Replacement Program for Patients Who Lost...
Press release article from: Business Wire September 13, 2005 700+ words
...N.J. -- Replacement Program Adds to Merck's $7.7 Million Cash and Product Donations to Date Merck & Co., Inc. announced today that...for patients who have lost their existing Merck medicines as a result of Hurricane Katrina...
Merck & Co., Inc. Breaks Ground for New Research Facility in Boston; Local,...
Press release article from: Business Wire October 1, 2001 700+ words
...BUSINESS WIRE)--Oct. 1, 2001 Merck & Co., Inc., a global, research...president of Emmanuel College, joined Merck executives in commemorating the start of construction and Merck's entrance to the Boston Research Community...
Merck Issues Response to Article Published in The Lancet.
Press release article from: PR Newswire Europe November 5, 2004 700+ words
HODDESDON, England, November 5 /PRNewswire/ -- Merck & Co., Inc. (Merck), the parent company of Merck Sharp & Dohme Limited, has issued the following statement in response to an article...
Merck Wins First California VIOXX(R) Case; California Jury Rejects Claim by...
Press release article from: Business Wire August 2, 2006 700+ words
...VIOXX case to go to trial, Grossberg v. Merck. "We are pleased that a state court jury...member of the defense team in Grossberg v. Merck. "The verdict is consistent with what we have always said. Merck acted appropriately in providing information...
Merck Focused on Future Growth Prospects.
Press release article from: Business Wire December 14, 2004 700+ words
WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. (NYSE:MRK) --Company...Bristol-Myers Squibb later this month --Merck expects to launch FOSAMAX plus vitamin D in 2005 --Merck accelerates planned FDA submissions for two...
Merck to Appeal Federal VIOXX(R) Verdict in Barnett v. Merck.
Press release article from: Business Wire August 17, 2006 700+ words
WHITEHOUSE STATION, N.J. -- Merck said it will appeal the decision returned...federal VIOXX case to go trial, Barnett v. Merck. "We disagree with the jury's verdict...VIOXX," said Phil Beck of Bartlit Beck, Merck's lead trial lawyer in the case. "Both...
Merck to Create New Patient Assistance Program for Vaccines.
Press release article from: Business Wire May 26, 2006 700+ words
WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. will create a new...announced today. Through this new program, Merck will provide free vaccines to adults who...and who are unable to afford vaccines. Merck's vaccines will become available through...
Merck Wins New Jersey VIOXX(R) Product Liability Case; Jury Rejects Claims of...
Press release article from: Business Wire July 13, 2006 700+ words
WHITEHOUSE STATION, N.J. -- Merck & Co., Inc. today said it was...rendering its verdict, the jury found that Merck acted responsibly in informing the medical...Hughes Hubbard & Reed, a member of Merck's defense team in Doherty v. Merck...
For more facts and information, see all results
©2010 Gale, a part of Cengage Learning. All rights reserved. About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily